Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
Most Cited Paper
in Hepatocellular Carcinoma Treatment and Prognosis
18 Months Post-Publication
Class of 2026
“Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026/
Topics
Hepatocellular carcinoma · liver transplantation · Immunotherapy · Intention-to-treat analysis · Multicenter study · VITALITY study · bridging therapy · Downstaging · Immune checkpoint inhibitor therapy · waitlist outcomes · Transplant outcomes · Allograft rejection · PD-1/PD-L1 inhibitor · tumor response · Milan criteria · transplant eligibility · Recurrence-free survival · Overall survival · Neoadjuvant immunotherapy · graft-versus-host disease · immunosuppression · alpha-fetoprotein · Downstaging · dropout rate · waitlist mortality
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Hepatocellular Carcinoma Treatment and Prognosis Papers, Class of 2026. https://pri.pepkio.com/top-papers/hepatocellular-carcinoma-treatment-and-prognosis/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459